What is Slate Medicines worth?
$176.0Mlast known valuation
Slate Medicines last raised $10.0M in its Early Stage VC (Feb 2026).
Free account
See the evidence behind this price
- ·Post-money valuations for all 1 rounds
- ·The complete investor list — 3 names
- ·Watchlist + deal alerts for Slate Medicines
Create free account
No card required
Funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Feb 2026 | Early Stage VC | $10.0M | ▮ | ▮ |
How Slate Medicines's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Slate Medicines, too few pricing signals exist to publish a composite mark; the figures above reflect the most recent observed valuation event. Full methodology →
Frequently asked
- What is Slate Medicines worth?
- Slate Medicines's last known valuation is $176.0M.
- How much has Slate Medicines raised?
- Slate Medicines has raised $133.0M in total funding across 1 recorded rounds.
- When did Slate Medicines last raise?
- Slate Medicines last raised in Feb 2026 (Early Stage VC), raising $10.0M.